Multiple Myeloma Comprehensive Panel Quantitative, Serum

The Protein Electrophoresis, Serum test measures the concentration and distribution of specific proteins (like albumin, alpha globulins, beta globulins, and gamma globulins) in the blood. Each of these plays a vital role in bodily functions. This test aids in the detection of abnormal proteins, particularly monoclonal (M) proteins. The presence of M proteins may indicate plasma cell disorders such as multiple myeloma (a blood cancer that affects plasma cells in the bone marrow). Also, this test helps diagnose and monitor various blood disorders.

The Immunoglobulin G test measures the concentration of IgG antibodies present in the serum. These antibodies are produced by the immune system in response to specific pathogens or infections. Elevated levels of IgG can indicate recent or chronic infections, while lower levels may suggest an impaired immune response or deficiency. This test is crucial for assessing an individual’s immune status and provides valuable information for doctors to make informed clinical decisions regarding diagnosis, treatment strategies, and ongoing management of various health conditions.

The Immunoglobulin M test measures the concentration of IgM antibodies in the blood. These antibodies are typically the first line of defense produced by the immune system during an initial exposure to a pathogen (bacteria, virus, etc). Elevated IgM levels indicate a recent or ongoing infection, while low or absent IgM levels suggest that an individual is either not currently infected or that the immune system has entered a later phase of response. This test is particularly useful for diagnosing acute infections and for distinguishing between new and past infections. 

The Immunoglobulin A test measures the concentration of IgA antibodies in the blood. The immune system produces these antibodies in response to pathogens and is primarily active in the mucosal membranes of the body, where they help prevent infections. Elevated levels of IgA may indicate chronic infections, autoimmune conditions, or inflammation, while lower levels can suggest immunodeficiency or impaired antibody production. This test provides essential insight into an individual’s mucosal immune health and is important for diagnosing and managing immune-related conditions.

The Beta-2 Microglobulin, Serum test measures the concentration of beta-2-microglobulin in the blood. B2M levels provide insight into both cellular activity and how effectively the kidneys are clearing proteins from the blood. High levels may indicate advanced stages of multiple myeloma, chronic lymphocytic leukemia, kidney disease, or other disorders affecting the immune system. Elevated B2M levels are often associated with poorer prognosis and can guide more aggressive treatment strategies. Low or normal levels typically indicate healthy kidney function and no significant increase in cell turnover from malignancy or immune activation.

By measuring serum B2M, doctors can evaluate disease progression, monitor treatment response, and support diagnosis and prognosis planning for blood cancers and related disorders.

The Kappa and Lambda - Freelite test measures the free (unbound) kappa and lambda light chains in the blood. Light chains are small proteins produced by plasma cells, a type of white blood cell. They can combine with other proteins (heavy chains) to form immunoglobulins, or antibodies, which help fight infections. When light chains are produced in excess, they do not combine with heavy chains and instead enter the blood in a "free" state, unbound to heavy chains. 

This test also determines the balance or ratio of kappa to lambda light chains in the blood (kappa: lambda ratio) which can provide valuable information about disorders related to plasma cells, such as multiple myeloma, a type of bone marrow cancer. It is also useful in monitoring treatment response and disease progression in these conditions.